AI can now create genome viruses in laboratories and redesign toxins to evade controls, raising biosafety alert and rise of ...

Smart AI governance isn’t about locking systems down or letting them run wild — it’s about giving teams freedom with just ...

Alumis is firmly in focus after announcing positive topline results from two Phase 3 trials (ONWARD1 and ONWARD2) evaluating envudeucitinib , its next-generation oral TYK2 inhibitor, in ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Addiction is one of the most intensely studied conditions in modern medicine, yet even with high‑resolution brain scans and ...

Oncology and tackling chronic issues like obesity are still the big drivers for growth in the biotech world. Combining ...

A major open-source photo repository developed at N.C. State University could be a significant step forward in helping unlock artificial intelligence’s potential for solving stubborn agricultural ...

A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

Researchers are trying to understand why some wild species do better than others over time, as the environment changes.

Twenty-five years of research into complex systems shows why artificial intelligence will always produce errors in healthcare ...